A comprehensive analysis of genomic determinants of response to immune checkpoint inhibitor-based immunotherapy.

被引：0
|
作者：
Yang, Jing [1 ]
Liu, Qi [1 ]
Shyr, Yu [1 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5018
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?
    Rizzo, Alessandro
    Ricci, Angela Dalia
    Di Federico, Alessandro
    Frega, Giorgio
    Palloni, Andrea
    Tavolari, Simona
    Brandi, Giovanni
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy
    Chen, Hsing-Wu
    Kuo, Yao-Wen
    Chen, Chung-Yu
    Chang, Chin-Hao
    Wang, Su-Mei
    Chien, Ying-Chun
    Lu, Wei-Chen
    Chen, Jo-Pai
    Chang, Cheng-Yu
    Wei, Yu-Feng
    Chang, Shih-Chieh
    Shu, Chin-Chung
    Wang, Jann-Yuan
    Liao, Wei-Yu
    Wang, Hao-Chien
    Yu, Chong-Jen
    ONCOLOGIST, 2024, 29 (04): : e498 - e506
  • [33] Immune checkpoint inhibitor-based combinations: is dose escalation mandatory for phase I trials?
    Simmet, V.
    Eberst, L.
    Marabelle, A.
    Cassier, P. A.
    ANNALS OF ONCOLOGY, 2019, 30 (11) : 1751 - 1759
  • [34] Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy
    Butner, Joseph D.
    Farhat, Maguy
    Cristini, Vittorio
    Chung, Caroline
    Wang, Zhihui
    STAR PROTOCOLS, 2022, 3 (04):
  • [35] Ceramide mimetics regulation of tumor cell response to immune checkpoint inhibitor immunotherapy
    Redd, Priscilla S.
    Lu, Chunwan
    Klement, John D.
    Ibrahim, Mohammed
    Yang, Dafeng
    Payne, Daniela
    Lebedyeva, Iryna
    Liu, Kebin
    CANCER RESEARCH, 2019, 79 (13)
  • [36] Gut microbes modulate host response to immune checkpoint inhibitor cancer immunotherapy
    Liu, Kebin
    Lu, Chunwan
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S608 - S610
  • [37] Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma
    Zhang, Wenjing
    Kong, Yujia
    Li, Yuting
    Shi, Fuyan
    Lyu, Juncheng
    Sheng, Chao
    Wang, Suzhen
    Wang, Qinghua
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [38] Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives
    Hossain, Sultana Mehbuba
    Carpenter, Carien
    Eccles, Michael R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [39] Comprehensive immune transcriptomic subtypes of colorectal cancer for development of precision immunotherapy.
    Jing, Zhou
    Guo, Xueguang
    Zhao, Jing
    Zhao, Xiaochen
    Zhang, Yuzi
    Huang, Mengli
    Cai, Shangli
    Zhu, Haitao
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Inhibition of host NOX1 blocks tumor growth and enhances checkpoint inhibitor-based immunotherapy
    Stalin, Jimmy
    Garrido-Urbani, Sarah
    Heitz, Freddy
    Szyndralewiez, Cedric
    Jemelin, Stephane
    Coquoz, Oriana
    Ruegg, Curzio
    Imhof, Beat A.
    LIFE SCIENCE ALLIANCE, 2019, 2 (04)
12345